The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 131, No 1, 87-91.
© 2000 American Dental Association

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SLAVKIN, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SLAVKIN, H. C.

OBSERVATIONS

HEALTH PROMOTION MADE EASY–GIVE A GIFT!



HAROLD C. SLAVKIN, D. D. S.

Preventing a disease or condition through health promotion efforts can be easy in theory, but difficult in practice. Humans apparently have evolved to react, whether to a dangerous animal, threatening enemies or a disease diagnosis. "Crisis mode" has become a common refrain, and with our busy lives, many of us seem to run in this fashion most of the time.

To achieve health promotion is a daunting goal. How do we educate and motivate members of a diverse culture who do not feel unwell, do not have high blood pressure and do not need surgery? It can be difficult to take steps to reduce the risks of diseases and conditions that don’t feel threatening, even if we are told we may be susceptible to them. The "it’ll never happen to me" refrain is a common one, and it has a purpose—it shelters us from constant thought and worry about what could go wrong in our lives. But sometimes it also keeps us from making evidence-based healthy choices that would help us live longer and live better.

For example, the American Cancer Society estimates that up to two-thirds of cancers could be prevented through changes in lifestyle.1 These changes, however, are fundamental ones—quitting smoking, eating a healthful diet, getting regular and vigorous exercise—that alter our entire lives and the way we approach them. Many of us see these changes as restrictive; some of us may feel deprived by having to give up what we enjoy, no matter what the potential health benefit. If only we could take a pill instead!

Western medicine has been disdained in the past for its "take a pill" approach—the idea that medication can cure all. The method is simple and fast and requires no overarching life changes. The problem is that pills don’t cure everything. Some patients continue to ask for antibiotics to cure viral infections, and some dentists and physicians continue to prescribe them.2 It’s a mindset that is difficult to discard, and even more difficult to change.

But this month I don’t want it to change. In fact, I want to encourage it. Because research from the past decade shows that if a woman takes one pill a day—one multivitamin containing folic acid—she can reduce the risks of neural tube birth defects in her children, and may reduce the risks of cleft lip and palate, placenta-mediated diseases and Down syndrome. And more research is beginning to indicate that folic acid supplementation for everyone—not just women of reproductive age—could reduce the risks of developing atherosclerosis, Alzheimer’s disease and certain cancers.

This list of preventive possibilities may make folic acid seem like a magic elixir. But research has shown that it just might be able to do all these things.

Folic acid (Figures 1Go3 and 2Go4) is found naturally as folate, which appears in such foods as citrus fruits and juices, leafy green vegetables, beans, peanuts, broccoli, asparagus, peas, lentils and whole-grain products. However, the synthetic folic acid is absorbed more easily by the body; in fact, some estimate that folic acid is nearly twice as "bioavailable" as folate.5



View larger version (126K):
[in this window]
[in a new window]
 
Figure 1. Folic acid is a water-soluble B vitamin that takes its name from "folium," the Latin word for "leaf." (Reprinted with permission of the National High Magnetic Field Laboratory, The Florida State University, from National High Magnetic Field Laboratory, Optical Microscopy Division.3)

 


View larger version (17K):
[in this window]
[in a new window]
 
Figure 2. The chemical structure of folic acid. (Reprinted with permission of Ed Uthman, M.D., from Uthman.4)

 
Because folic acid takes part in such vital activities as the growth and differentiation of red blood cells and the production of DNA, it’s not surprising that it has been linked to a wide range of diseases and conditions. The strongest relationship is between folic acid supplementation and neural tube defects, or NTDs, with which an estimated 2,500 infants are born in the United States each year.6 Common NTDs include spina bifida and anencephaly. Spina bifida, which affects about one in every 2,000 live births, produces varying degrees of paralysis and incontinence; in about 30 percent of cases, there is mental retardation.7 Many patients with spina bifida require leg braces, crutches or other devices to help them walk, as well as have chronic bladder infections and kidney problems. Anencephaly is less common, but fatal—newborns with this condition are missing most or all of their brain tissue and are stillborn or die shortly after birth.

The causes of about 60 percent of all birth defects are still largely unknown. But each day, 411 babies are born with some type of birth defect.8 The effects of many are multifaceted and lifelong. From an economic standpoint, the treatment of a child with Down syndrome over his or her entire lifetime costs nearly half a million dollars.9

Strong evidence of folic acid’s benefit appeared in 1991, with the publication of the results of a prevention trial involving more than 1,800 women.10 All had had previous pregnancies affected by NTDs, which increased the risk of a subsequent affected pregnancy. The study—conducted at 33 medical centers in seven countries—found that 4,000 micrograms of folic acid taken supplementally provided a 72 percent protective effect and no demonstrable harm.11

The next year, a Hungarian study found that supplementation with 800 µg of folic acid also reduced the risk of NTDs in women who were not at increased risk of experiencing such a pregnancy—they had either never been pregnant before or had normal previous pregnancies. Of the babies born to the more than 2,000 women in the study who received folic acid, none had an NTD; in babies born to women in the control group, six NTDs were identified.11

Based on this evidence, as well as on intervention clinical trial studies of folate supplementation that related NTDs to folate intake and folate concentrations, the U.S. Public Health Service, or PHS, recommended that all women in the United States who might become pregnant should consume 400 µg of folic acid daily to reduce the risk of NTDs in their offspring.12 Other public and private agencies and organizations—including the U.S. Food and Drug Administration, or FDA; the Teratology Society; and the Spina Bifida Association of America—recommend daily intake of folic acid.

If the take-home message is that folic acid is for pregnant women, the message is incomplete. Because NTDs develop in the first 28 days after conception, by the time a woman knows she is pregnant, it’s too late for folic acid to help. And because half of the pregnancies in this country are unplanned, folic acid recommendations are for all women—not only those planning a pregnancy.13

To make it easier for women to increase their folic acid intake, in 1996 the FDA issued regulations requiring the addition of 140 µg of folic acid per 100 grams of grain to cereals, breads, pastas and other foods labeled "enriched." However, most women will not be able to rely on enriched foods alone; it is estimated that this additional amount of folic acid will prevent only 5 to 20 percent of the NTDs that folic acid can affect.14

It may be difficult enough to persuade people to alter their lifestyles by quitting tobacco use or adjusting to a low-fat diet. But even recommendations to take a vitamin supplement containing folic acid—begun in the early 1990s—all too often have not been heard. Although approximately 25 percent of the U.S. population takes vitamin supplements,5 not all of that 25 percent are women, and not all of those supplements contain folic acid. Since the publication of those landmark studies tying folic acid supplements to a reduction in NTDs, public education efforts have attempted to let women know about the incredible benefits of taking a multivitamin containing folic acid. However, according to the March of Dimes, the proportion of women taking a multivitamin containing folic acid has not increased.15 The organization reports that only 18 percent of nonpregnant women aged 18 to 24 years, 30 percent aged 25 to 34 years and 33 percent aged 35 to 44 years are taking folic acid. Percentages were even lower among women with less education and smaller household incomes.15

However, more women now know about folic acid; from 1995 to 1998, the percentage of women who had heard of the vitamin increased from 52 percent to 68 percent. But only 32 percent were taking folic acid in 1998 (a weak increase from 28 percent in 1995), and only 13 percent knew that folic acid could prevent birth defects.15 Among Canadian women aged 16 to 40 years who completed a questionnaire while visiting their family physicians in 1996, only 22.5 percent knew that NTDs were preventable, and less than 2 percent knew that folic acid supplements taken before conception could reduce the risk of NTDs.16

In the United Kingdom, peri-conception folate supplementation also has been encouraged since the early 1990s, and the U.K. Department of Health recommends that all women of childbearing age take 400 µg of folic acid daily.17 However, no concurrent decline in NTDs has been observed by regional congenital anomaly registers.18

Ironically, serum folate levels in women in the United States do seem to be increasing, possibly because of food fortification. From 1994 to 1998, median serum folate values in clinical specimens increased, and the percentage of low values decreased.19 This raises a key difficulty in this, and many other, research areas: how do we measure folate and determine its availability and actual use, and which measurements are important? Most research uses either serum folate or red blood cell folate as a measure of folate status, but these methods can differ by as much as a factor of nine.20 A standardization program is needed to ensure the comparability of data and help further research on folic acid fortification and supplementation.

Still, the benefits of daily folic acid supplementation for women of childbearing age far exceed the risks. If all women received the recommended folic acid supplements, the incidence of NTDs could be reduced by as much as 70 percent.21 For women who already have had a pregnancy affected by an NTD, the PHS recommends consulting with a health professional about taking a much larger dose, as much as 4,000 µg (4 milligrams). In the past, there was a concern that high doses of folic acid could mask the symptoms of vitamin B12 deficiency, a sign of pernicious anemia. But this condition is rare in young and middle-aged people, and there now are other tests to check for a B12 deficiency that will reveal it, even if large amounts of folic acid are present.22 Folic acid supplementation shows a cost:benefit ratio that would make any economist’s mouth water. The lifetime health care costs of one child with spina bifida average nearly $300,0009; a bottle of 100 folic acid–enriched vitamins costs less than $8. Imagine if every woman received a gift of a one-year supply of multivitamins supplemented with folic acid at a cost of less than $30.

Educational efforts must persist, particularly those targeted at women younger than 25 years of age. Although only 18 percent of these women take supplemental folic acid, this age group accounts for nearly 40 percent of all births in the United States.23 As health care professionals, we should capitalize on a situation in which a simple preventive strategy can have a profound effect. What would make a more original and health-promoting wedding gift (or birthday gift, going-away present, holiday office gift) than a supply of vitamins, enriched with folic acid?

I could end this month’s column here and still have illustrated a powerful health-promotion strategy. But there’s more. Besides NTDs, folic acid supplementation has been associated with a reduction in orofacial clefts, congenital heart defects, obstructive urinary tract anomalies, limb deficiencies and congenital hypertrophic pyloric stenosis, as well as reductions in placenta-related diseases, preterm deliveries and intrauterine growth retardation. Adequate folic acid intake in adults has been associated with a reduction in cardiovascular disease and some cancers,24,25 and folate mouthwash may reduce the severity of gingivitis.26,27

How does folic acid work its magic? The answer is still incomplete, but evidence is mounting that for some people, folic acid supplements may help overcome difficulties in folate metabolism brought about by genetic polymorphisms. As many as one in seven people may carry a genotype that causes them to have a deficiency in folic acid, even if they are consuming a diet containing the recommended amount of folate. These people have difficulty in folate metabolism, resulting in lower folic acid levels in the blood.14

Research has pinpointed a specific genetic mutation in a gene called methylenetetrahy-drofolate reductase, or MTHFR, that is involved in folate metabolism. The mutation is small—one nucleotide has been changed from cytosine to thymine. Women with this genetic polymorphism in the MTHFR gene are 2.5 times more likely to have a child with Down syndrome.28 This same mutation also is associated with inflammatory bowel disease, colon cancer, oral clefting and higher levels of homocysteine.29-32

Precisely how folic acid protects against NTDs is not known, but supplementation may overcome the metabolic roadblock of certain MTHFR polymorphisms, rather than counteract a deficiency.33,34 In an interesting twist to the story, taking supplemental folic acid and eating fortified foods seem to be a better strategy than simply increasing the amount of foods containing natural folate. In a three-month intervention study in the United Kingdom, only the first two of these measures increased folate concentrations.17 Although these results make sense—folic acid is easier for the body to metabolize than is folate—the usual mantra in nutrition is for people to use supplements only when absolutely necessary, and to rely on dietary changes as a first line of defense.

In the case of folic acid, supplements and fortified foods are that first line. Unfortunately, not all supplements are created equal. In a 1997 study of a variety of brand-name and generic multivitamin products, only one-third met United States Pharmacopeial Convention standards for folic acid release. Most of the products missed the cutoff levels by a wide margin; folic acid availability from two of the products was less than 25 percent.35


   CONCLUSION
 TOP
 CONCLUSION
 REFERENCES
 
In the end, then, it’s never just as easy as taking a pill. Educational efforts and better communication by health care providers must be combined with stricter pharmacological and pharmaco-genetic standards. All women—and most critically, those women who have had a pregnancy affected by an NTD—should consider the benefits of taking a multivitamin supplement that contains folic acid. It’s an excellent gift for any woman, and the first gift a mother can give her child.


View this table:
[in this window]
[in a new window]
 
FOR FURTHER INFORMATION

 


   FOOTNOTES
 

The views expressed are those of the author and do not necessarily reflect the opinions or official policies of the American Dental Association.


Dr. Slavkin is director, National Institute of Dental and Craniofacial Research, 31 Center Drive, MSC 2290, Building 31, Room 2C39, Bethesda, Md. 20892-2290. Address reprint requests to Dr. Slavkin.


   REFERENCES
 TOP
 CONCLUSION
 REFERENCES
 

  1. American Cancer Society. The importance of nutrition in cancer prevention. Available at: "http://www2.cancer.org/prevention/index.cfm?prevention=1". Accessed Oct. 6, 1999.

  2. Hueston W, Mainous A, Ornstein S, et al. Antibiotics for upper respiratory tract infections. Arch Fam Med 1999;8(5):426–30.[Abstract/Free Full Text]

  3. National High Magnetic Field Laboratory, Optical Microscopy Division. Folic acid (folate, vitamin B-9). Molecular expressions: the vitamin collection. Available at: "http://microscopy.fsu.edu/vitamins/pages/folicacid.html". Accessed Oct. 6, 1999.

  4. Uthman E. Nutritional anemias and anemia of chronic disease. Available at: "http://www.neosoft.com/~uthman/nutritional_anemia/nutritional_anemia.html". Accessed Oct. 6, 1999.

  5. Oakley GP Jr. Eat right and take a multi-vitamin. N Engl J Med 1998;338(15):1060–1.[Free Full Text]

  6. American Academy of Pediatrics, Committee on Genetics. Folic acid for the prevention of neural tube defects. Pediatrics 1999;104(2 pt 1):325–7.[Abstract/Free Full Text]

  7. U.S. Food and Drug Administration. How folate can help prevent birth defects. Available at: "http://vm.cfsan.fda.gov/~dms/fdafolic.html". Accessed Oct. 4, 1999.

  8. March of Dimes. On an average day in the U.S. Available at: "http://www.modimes.org/HealthLibrary2/factsfigures/avgday.htm". Accessed Oct. 6, 1999.

  9. March of Dimes. Economic costs of birth defects. Available at: "http://www.modimes.org/HealthLibrary2/factsfigures/costprev.htm". Accessed Oct. 4, 1999.

  10. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. MRC Vitamin Study Research Group. Lancet 1991;338(8760):131–7.[Medline]

  11. Czeizel AE, Dudas I. Prevention of the first occurrence of neural-tube defects by peri-conceptional vitamin supplementation. N Engl J Med 1992;327(26):1832–5.[Abstract]

  12. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Morb Mortal Wkly Rep 1992;41(RR-14):1–7.

  13. U.S. Food and Drug Administration. FDA consumer magazine: health pregnancy, healthy baby. Available at: "http://www.fda.gov/fdac/features/1999/299_baby.html". Accessed Oct. 6, 1999.

  14. March of Dimes. Folic acid fact sheet. Available at: "http://www.modimes.org/Programs2/FolicAcid/FASheet.htm". Accessed Oct. 4, 1999.

  15. March of Dimes. Folic acid Gallup survey results, 1995 and 1997. Available at: "http://www.modimes.org/HealthLibrary2/factsfigures/folicacid.htm". Accessed Oct. 4, 1999.

  16. Bonin MM, Bretzlaff JA, Therrien SA, Rowe BH. Knowledge of periconceptional folic acid for the prevention of neural tube defects: the missing links. Northeastern Ontario Primary Care Research Group. Arch Fam Med 1998;7(5):438–42.[Abstract/Free Full Text]

  17. Cuskelly GJ, McNulty H, Scott JM. Effect of increasing dietary folate on red-cell folate: implications for prevention of neural tube defects. Lancet 1996;347(9002):657–9.[Medline]

  18. Abramsky L, Botting B, Chapple J, Stone D. Has advice on periconceptional folate supplementation reduced neural-tube defects? Lancet 1999;354(9183):998–9.[Medline]

  19. Lawrence JM, Petitti DB, Watkins M, Umekubo MA. Trends in serum folate after food fortification. Lancet 1999;354(9182):915–6.[Medline]

  20. Gunter EW, Bowman BA, Caudill SP, Twite DB, Adams MJ, Sampson EJ. Results of an international round robin for serum and whole-blood folate. Clin Chem 1996;42:1689–94.[Abstract/Free Full Text]

  21. March of Dimes. Spina bifida. Available at: "http://www.modimes.org/HealthLibrary2/FactSheets/Spina_Bifida.htm". Accessed Oct. 4, 1999.

  22. Centers for Disease Control and Prevention. Preventing neural tube defects: a prevention model and resource guide. Available at: "http://www.cdc.gov/nceh/prevent/flo/ntd/preface/can.htm". Accessed Oct. 4, 1999.

  23. Knowledge and use of folic acid by women of childbearing age—United States, 1997. MMWR Morb Mortal Wkly Rep 1997; 46(31):721–3.[Medline]

  24. Hall J, Solehdin F. Folic acid for the prevention of congenital anomalies. Eur J Pediatr 1998;157(6):445–50.[Medline]

  25. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer 1999;79(11-12):1917–22.[Medline]

  26. Pack AR. Folate mouthwash: effects on established gingivitis in periodontal patients. J Clin Periodontol 1984;11(9):619–28.[Medline]

  27. Pack AR, Thomson ME. Effects of topical and systemic folic acid supplementation on gingivitis in pregnancy. J Clin Periodontol 1980;7(5):402–14.[Medline]

  28. James SJ, Pogribna M, Pogribny IP, et al. Abnormal folate metabolism and mutation in the methylenetetrahydrofolate reductase gene may be maternal risk factors for Down syndrome. Am J Clin Nutr 1999;70(4):495–501.[Abstract/Free Full Text]

  29. Mahmud N, Molloy A, McPartlin J, et al. Increased prevalence of methylenetetrahydro-folate reductase C677T variant in patients with inflammatory bowel disease, and its clinical implications. Gut 1999;45(3):389–94.[Abstract/Free Full Text]

  30. Ma J, Stampfer MJ, Christensen B, et al. A polymorphism of the methionine synthase gene: association with plasma folate, vitamin B12, homocyst(e)ine, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8(9):825–9.[Abstract/Free Full Text]

  31. Mills JL, Kirke PN, Molloy AM, et al. Methylenetetrahydrofolate reductase thermolabile variant and oral clefts. Am J Med Genet 1999;86(1):71–4.[Medline]

  32. Alpert MA. Homocyst(e)ine, atherosclerosis, and thrombosis. South Med J 1999;92(9):858–65.[Medline]

  33. Yates JR, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, Clark BJ. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin Genet 1987;31(5):279–87.[Medline]

  34. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp 1994;181:180–7.[Medline]

  35. Hoag SW, Ramachandruni H, Shangraw RF. Failure of prescription prenatal vitamin products to meet USP standards for folic acid dissolution. J Am Pharm Assoc (Wash) 1997;NS37(4):397–400.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SLAVKIN, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SLAVKIN, H. C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS